Kwangdong Healthbio Co., Ltd. (XKON:086220)
1,397.00
-3.00 (-0.21%)
At close: Feb 27, 2026
Kwangdong Healthbio Market Cap
Kwangdong Healthbio has a market cap or net worth of 17.72 billion as of February 27, 2026. Its market cap has increased by 6.09% in one year.
Market Cap
17.72B
Enterprise Value
n/a
Revenue
38.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,397.00
Market Cap Chart
Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 17.72B, a decrease of -14.27%. That is a compound annual growth rate of -1.71%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Union Korea Pharm | 19.70B |
| WooGene B&G | 21.93B |
| CXI Healthcare Technology Group | 13.77B |
| BIFIDO | 24.46B |
| Future Medicine | 12.80B |
| Bioten | 11.79B |
| Daesung Microbiological Labs. | 26.75B |
| Pharmsville | 27.82B |